Home » Topics » Regulatory

Regulatory
RSS

Ofloxacin ophthalmic solution receives FDA approval

May 31, 1996

FDA approves piperacillin sodium/tazobactam sodium for new indication

May 31, 1996

Hyal's 3% diclofenac gel: Positive phase III results announced

May 31, 1996

Forskolin studied as rescue therapy for impotence

May 24, 1996

Nitroglycerin gel enhances erectile function in healthy males

May 24, 1996

Clomipramine for treatment of premature ejaculation

May 24, 1996

Losartan for treatment of erectile dysfunction

May 24, 1996

MacroChem's erectile dysfunction therapy moves to phase I/II in U.S.

May 24, 1996

Lovastatin potential for use in post-transplant patients

May 24, 1996

Transdermal scopolamine studied in hypertensive patients

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...